StockVS

Inflection Point Acquisition Corp. III (IPCX) 股票分析

金融服务

Inflection Point Acquisition Corp. III

$10.31

+$0.00 (+0.00%)

最后更新: 2026年5月26日

价格走势

分析

公司概述

Inflection Point Acquisition Corp. III operates as a special purpose acquisition company, or SPAC, which does not currently maintain significant operational activities but is structured to pursue a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more target businesses. The company functions within the Financial Services sector, specifically categorized under the Shell Companies industry, indicating its role as an intermediary vehicle designed to raise capital for future mergers rather than generating revenue through traditional business operations. As of the latest data, the company holds a market capitalization of $352.66M, while its annual revenue and employee count are not available for reporting. The absence of reported revenue and employee figures alongside a market cap of $352.66M suggests that the company's value is derived entirely from its trust account structure and potential merger targets, rather than from ongoing business performance or operational scale. This valuation reflects the market's pricing of the SPAC's potential to identify and acquire a private company, positioning it as a financial instrument for investors seeking exposure to future business combinations rather than established cash flow generation.

财务健康

The company reports a net income of $498,416 for the trailing twelve months, whereas both its revenue and EBITDA figures are not available, a discrepancy that reveals a cost structure where reported earnings likely stem from non-operating sources such as trust interest income rather than core business operations. Free cash flow is not available for the company, indicating that there is no significant operating cash generation to support capital expenditures or debt repayment from current business activities. All three key margin metrics, including gross margin, operating margin, and profit margin, are recorded at 0.0%, which indicates that the company has not yet engaged in significant commercial transactions that would allow for the calculation of traditional profitability ratios based on sales. The balance sheet shows a cash position of $1.13M against total debt of $80,825, while the debt-to-equity ratio is not available; however, the absolute debt level is significantly lower than the cash on hand, suggesting a conservative liquidity stance despite the lack of equity data for the ratio calculation. The current ratio stands at 2.84, a figure that indicates strong short-term liquidity and the ability to cover short-term obligations with current assets without reliance on external financing. Return on Equity and Return on Assets are not available, meaning that traditional return metrics cannot be calculated to evaluate management effectiveness at this stage of the company's lifecycle.

估值评估

The trailing twelve-month P/E ratio is 511.50, while the forward P/E ratio is not available, a difference that implies the market is pricing in potential future earnings growth that has not yet materialized in the financial statements. The price-to-book ratio is -25.83, a negative figure that indicates the market value of the company is below its book value, often seen in SPACs where the net asset value includes trust funds that may not fully align with traditional equity valuations. Neither the price-to-sales ratio nor the EV/EBITDA multiple is available, suggesting that alternative valuation metrics are not meaningful for a shell company with negligible or non-existent sales and earnings history. Over the past year, the stock has traded between a 52-week high of $10.35 and a 52-week low of $10.05, placing the current trading price in a narrow range that reflects limited volatility typical of non-operating shell entities. The beta value is not available, preventing a direct comparison of price volatility relative to the broader market, though the tight trading range implies low sensitivity to general market movements compared to active equity securities.

Growth & Income

Revenue growth and earnings growth year-over-year are not available due to the company's lack of significant operational history, making it impossible to determine if earnings are growing faster or slower than revenue in a traditional sense. As a non-dividend payer, the company does not distribute cash to shareholders, indicated by a dividend yield of N/A and a payout ratio of 0.0%, which means all available earnings are theoretically retained or held in trust for future business combination expenses. Since the company does not pay dividends, any realized earnings from trust accounts or future operations would be reinvested into the acquisition process rather than distributed as income to shareholders. The overall growth and income profile is currently undefined, characterized by a lack of historical data and a focus on capital preservation within the trust structure until a definitive business combination is executed.

同行比较

Inflection Point Acquisition Corp. III (IPCX) 在壳公司行业运营。以下是其与市值最接近的同行的比较:

公司 代码 市值 市盈率
Inflection Point Acquisition Corp. III IPCX $355.42M 114.6
Twenty One Capital, Inc. XXI $2.49B N/A
Churchill Capital Corp X CCCX $711.00M N/A
Drugs Made In America Acquisition II Corp. DMII $641.46M 77.5

壳公司行业平均市盈率为82.8倍。Inflection Point Acquisition Corp. III的市盈率为114.6。

本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。

关于Inflection Point Acquisition Corp. III

Inflection Point Acquisition Corp. III does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Inflection Point Acquisition Corp was incorporated in 2024 and is headquartered in New York, New York.

公司简介以英文显示。

关键指标

市值
$355.42M
市盈率
114.56
52周最高
$10.35
52周最低
$10.05
平均成交量
66.88K

数据由Yahoo Finance通过yfinance提供。每日更新。

公司信息

交易所
NASDAQ
国家
United States